Our research has been published in “Experimental and therapeutic medicine” cited at PubMed Central, US National Library of Medicine, National Institutes of Health; “CellR4”, the official journal of The Cure Alliance...
Our stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety. The studies have been conducted following approval by an Investigational Research Board...
Our work is grounded in published, peer-reviewed scientific research. Our cellular products are investigational and are studied under appropriate research protocols.
Wharton's Jelly and umbilical cord blood are well-characterized biological materials that are the subject of ongoing scientific research in the field of regenerative medicine.
We are committed to conducting our research and operations in accordance with applicable laws and regulations. Our products are investigational and have not been approved by the FDA.
Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells that form the diverse tissues of the human body. Stem cells have the power to divide virtually without limits and convert or develop into specialized cells that can replace injured or damaged tissue. Additionally, stem cells are known to secrete cytokines (small secreted proteins released by cells) that are studied for their immunomodulatory properties. Tissue-specific stem cells (“adult” or “somatic” stem cells) are already specialized and can produce different cell types for the specific tissue or organ in which they reside. Stem cell research is an active and evolving field of regenerative medicine that continues to be the subject of ongoing scientific study worldwide.
Human Umbilical cord blood (hUCB)
Adipose Tissue derived stem cell
BHI Stem Cells has taken every precaution to ensure the safety and viability of administered stem cells. BHI stem cells are tested for sterility, infectious diseases and have high cell count and viability. Every unit of Human Umbilical Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells has the Cell Quality Certificate with the following information: Virus Tests (Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency virus and Treponema pallidum), Microbiological Tests (Bacteria, Fungus, Mycoplasma, Endotoxin), the cell count and viability.

Cell Quality Certificate for Human Umbilical Cord Blood Mononuclear Cells
Issued Aug 2022
View Certificate
Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation
View Research
A Clinical Trial Report of Autologous Bone Marrow Derived Mesenchymal Stem Cell Transplantation in Patients with Spinal Cord Injury
View Research
Allogeneic umbilical cord blood mononuclear cell therapy for spinal cord injury
View Research
A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis
View Research
Case Series: Dendritic Cell- Cytokine Induced Killer Cell Therapy in Subjects with Chronic Lymphocytic Leukemia and Peritoneal Cancer
View Research
Evaluation of Immune response to Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation
View Research
This original clinical study article describes the use and safety of umbilical cord wharton’s jelly derived-mesenchymal stem cell therapy for a range of indications.
View Research
Regenerative medicine is an active and rapidly evolving field of scientific research. BHI Stem Cells is committed to conducting its research activities in a manner that seeks to follow the applicable laws and regulations of each jurisdiction in which it operates. Our cellular products are investigational. They have not been approved or licensed by the U.S. Food and Drug Administration (FDA), and no statement on this website should be interpreted as a representation that any product is FDA-approved, is the subject of an effective Investigational New Drug (IND) application or Biologics License Application, or has been demonstrated to be safe or effective for any use. Any references to research relating to specific cell types are provided for general educational purposes only.
BHI Stem Cells works with medical professionals, scientific advisors, and regulatory specialists who support its research and education activities in the field of regenerative medicine. The organization is focused on contributing to the scientific understanding of cellular biology through responsible, well-documented research conducted in accordance with applicable regulatory requirements. The information presented on this website is intended for general educational purposes and does not describe any product or service that is offered as a medical treatment.
